Your partner for
Antibody & ADC development
Start your project
Partnering to
accelerate and secure
your antibody drug development.
MImAbs is a preclinical CRO specialized in antibody & ADC development. Our mission is to empower clients through scientific expertise, flexible collaboration, and tailored support to achieve their specific goals.
12+
years antibody expertise
All-in-one
services, made in Europe
Flexible
fee-for-service
Meet your development needs
Derisk your program
By managing risks early and throughout preclinical stages.
Accelerate timelines
By selecting the best candidates
early based on function.
Streamline antibody development
By offering an integrated development with proven results.
Engage Expertise
By sharing know-how, we guide your antibody projects.
Flexible Solutions
By customizing approaches and technologies, we fit your unique needs.
Want to explore more of MImAbs’ applications ?
See our applicationsAntibody services
A modular expert platform for antibody generation, engineering and characterization.
Ab Discovery
Fast-track leads with single B-cell screening
Ab Engineering
Optimizing antibodies for function and developability
Protein Bioproduction
Custom antibody production at scalable, high quality
Ab Conjugation
Tailored conjugation for optimal ADC formats
Functional Characterization
Advanced QC methods securing consistent developability
Biological Efficacy
Functional proof-of-concept in relevant biological assays
Discover the steps of our expertise
Project analysis
Expert advice and development plans to set your antibody project on the right path.
mAb Generation
Efficient antigen/mRNA immunisation and single B cell screening for lead discovery.
mAb Engineering
Humanization and multispecific designs to optimize developability and function.
Bioproduction
Scalable production up to 400mg with conjugate characterization and formulation.
Pharmacology
In vitro and in vivo assays to evaluate efficacy, toxicity and immune profiling.
Get in touch with MImAbs experts
Need expert support in antibody discovery and development?
Contact MimAbs to discuss your project, our team will support you in the scientific study and strategic development planning of your project.
Contact an expertMImAbs DNA
Created in 2011, MImAbs is now an agile fee-for-service company located in Marseille Immunopôle, a leading hub for immunology innovation. Since 2023, it has been part of Janvier Group Bioscience, combining flexibility with scientific excellence.
Discover MimAbs
Science-Driven Expertise
Our discovery and development programs are rooted in deep scientific knowledge and innovative methodologies, ensuring robust and reliable antibody-based solutions.
Antibody & ADC Excellence
We harness advanced antibody technologies and conjugation expertise to deliver high-quality therapeutics, diagnostics, and research tools, including antibody-drug conjugates (ADCs) for targeted application.
Partnership-Focused
Collaboration is at the heart of our approach. We adapt to your goals with tailored strategies, flexible support, and scientific guidance to accelerate discovery and development.
Quality certified
We have a high-standard ISO9001 certification that establishes the requirements for a quality management system to improve efficiency and increase satisfaction.
They trust us
